Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norimitsu Shirai

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Toxicologic Pathology|October 2, 2010
Renal dysplasia in Beagle dogs: four casesMarc C Bruder, Ahmed M Shoieb, Norimitsu Shirai, et al.
Toxicologic Pathology|May 31, 2025
Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety StudiesLila Ramaiah, Tara Arndt, Gareth Thomas, et al.
Carcinogenesis|August 22, 2002
Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesisNorimitsu Shirai, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Cancer Letters|January 16, 2002
Summation of initiation activities in the liver after partial hepatectomyHiroki Sakai, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Journal of Cancer Research and Clinical Oncology|May 14, 2003
High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazineHiroki Sakai, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Toxicologic Pathology|April 29, 2014
The relationship of glucokinase activator-induced hypoglycemia with arteriopathy, neuronal necrosis, and peripheral neuropathy in nonclinical studiesJohn C Pettersen, John Litchfield, Natasha Neef, et al.
Cancer Letters|December 25, 2004
Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient miceTakeshi Iidaka, Tetsuya Tsukamoto, Yukari Totsuka, et al.
Toxicologic Pathology|March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
International Journal of Toxicology|May 23, 2022
Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™Jean G Sathish, Siddhartha Bhatt, Jamie K DaSilva, et al.
Nature Metabolism|September 15, 2020
De novo lipogenesis is essential for platelet production in humansKenneth L Kelly, William J Reagan, Gabriele E Sonnenberg, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Toxicologic Pathology|October 2, 2010
Renal dysplasia in Beagle dogs: four casesMarc C Bruder, Ahmed M Shoieb, Norimitsu Shirai, et al.
Toxicologic Pathology|May 31, 2025
Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety StudiesLila Ramaiah, Tara Arndt, Gareth Thomas, et al.
Carcinogenesis|August 22, 2002
Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesisNorimitsu Shirai, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Cancer Letters|January 16, 2002
Summation of initiation activities in the liver after partial hepatectomyHiroki Sakai, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Journal of Cancer Research and Clinical Oncology|May 14, 2003
High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazineHiroki Sakai, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Toxicologic Pathology|April 29, 2014
The relationship of glucokinase activator-induced hypoglycemia with arteriopathy, neuronal necrosis, and peripheral neuropathy in nonclinical studiesJohn C Pettersen, John Litchfield, Natasha Neef, et al.
Cancer Letters|December 25, 2004
Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient miceTakeshi Iidaka, Tetsuya Tsukamoto, Yukari Totsuka, et al.
Toxicologic Pathology|March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
International Journal of Toxicology|May 23, 2022
Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™Jean G Sathish, Siddhartha Bhatt, Jamie K DaSilva, et al.
Nature Metabolism|September 15, 2020
De novo lipogenesis is essential for platelet production in humansKenneth L Kelly, William J Reagan, Gabriele E Sonnenberg, et al.
Pageof 3